Vontobel Holding
FNCH

Vontobel Holding’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Vontobel Holding’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-833
Closed -$325K – 1242
2021
Q3 		$325K Hold
833
– – ﹤0.01% 914
2021
Q2 		$341K Buy
+833
New +$361K ﹤0.01% 875

Other funds holding FNCH

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
TA
TRB Advisors New York $146M AUM 3.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vontobel Holding's FNCH Position: Q4 2021 in Review

Vontobel Holding sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q4 2021, closing a stake of 833 shares — an estimated $325K sold.

Vontobel Holding first reported a position in FNCH in Q2 2021 and held it in 2 quarters. The position peaked at $341K in Q2 2021. 51 funds tracked by Wall St. Rank hold FNCH as of Q4 2021.

  • Vontobel Holding reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Vontobel Holding sold 833 Finch Therapeutics Group, Inc. Common Stock shares in Q4 2021, an estimated $325K.
  • Vontobel Holding first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Vontobel Holding's Finch Therapeutics Group, Inc. Common Stock position peaked at $341K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q4 2021.

Based on Vontobel Holding's 13F filing for Q4 2021, filed 10 Feb 2022.